In 2023, BMW Group India achieved notable success, with sales totaling 14,172 units, marking an impressive 18 percent year-on-year (YoY) growth. This exceptional performance was attributed to all three of its brands – BMW, Mini, and BMW Motorrad – each achieving their highest-ever sales in the country.
Key Highlights:
– BMW sold 13,303 units, while Mini recorded sales to 869 buyers.
– BMW Motorrad experienced a 20 percent YoY growth, registering 8,768 units sold.
– BMW’s EV sales reached 1,474 units, reflecting an impressive 325 percent YoY growth.
– Q4 CY23 was the best-ever quarter, with BMW, Mini, and BMW Motorrad achieving record sales.
– December 2023 marked the best-ever sales month for both BMW and Mini.
Model-wise Breakdown:
– SUVs contributed 54 percent to BMW’s 2023 sales, while sedans followed closely at 46 percent.
– The BMW 3 Series led the sales charts, accounting for 20 percent of the overall sales with 2,702 units.
– The X1 crossover secured the second position with 2,633 units, contributing 20 percent to the total volumes.
– The flagship X7 SUV ranked third with 1,513 units, making an 11 percent sales contribution for the year.
Electric Vehicle (EV) Sales:
– BMW’s EV portfolio, comprising the 3-door Mini hatchback, BMW iX1, i4, iX, and i7, achieved 1,474 units in sales, exhibiting an exceptional YoY growth of 325 percent.
– The iX emerged as the top-selling luxury EV in India, with 639 units sold in 2023.
– The Mini 3-door Cooper SE hatchback found homes with 239 buyers.
Market Position and Future Plans:
– BMW Group India maintained its leadership in the EV segment for the second consecutive year, boasting over 50 percent market share in the luxury segment, as per Vahan data.
– EV sales represented 10 percent of the total sales by the end of 2023, and the company aims to reach 25 percent by 2025.
– Plans for 2024 include introducing two additional EVs.
– Despite strong demand, the company aims to fulfill all committed deliveries of the i4 by March 2024, with certain models witnessing a two-three month waiting period.
+ There are no comments
Add yours